Company Profile
Laboratorio Farmaceutico Erfo S.p.A. specializes in the formulation, production and marketing of nutraceuticals, resulting from continuous research and development. The activity is organized around 2 poles:
- Diètnatural: a format designed and developed by the company, dedicated to the sale of nutraceutical products dedicated to slimming and continuous assistance through operators specialized in nutrition within the framework of wellness therapy ;
- Medical Division: a line of nutraceutical products launched in 2021, dedicated to three specific therapeutic areas (gastroenterology, neurology and musculoskeletal) with major developments planned in the orthopedic field.
- Diètnatural: a format designed and developed by the company, dedicated to the sale of nutraceutical products dedicated to slimming and continuous assistance through operators specialized in nutrition within the framework of wellness therapy ;
- Medical Division: a line of nutraceutical products launched in 2021, dedicated to three specific therapeutic areas (gastroenterology, neurology and musculoskeletal) with major developments planned in the orthopedic field.
Key Executives
Chairman and Chief Executive Officer | |
Chief Investor Relations Officer | |
Chief Financial Officer |
Key Figures
Millenium | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|
Net sales | 4,624,287 | 4,818,434 | 3,904,323 | 4,348,805 | 3,794,542 |
Consumed purchases | 1,319,870 | 1,370,627 | 1,078,758 | 1,188,229 | 1,027,945 |
Labour costs | 890,572 | 694,251 | 654,178 | 772,173 | 630,898 |
Operating profit | 987,032 | 1,580,046 | 1,487,526 | 1,807,954 | 1,640,591 |
Income tax | 232,433 | 389,859 | 350,878 | 483,776 | 458,489 |
Net income | 716,072 | 1,165,976 | 1,139,930 | 1,310,094 | 1,168,785 |
Net income (Group share) | 716,072 | 1,165,976 | 1,139,930 | 1,310,094 | 1,168,785 |
Fiscal year end | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
Length of fiscal year (month) | 12 | 12 | 12 | 12 | 12 |
Currency & Unit | EUR - unit | EUR - unit | EUR - unit | EUR - unit | EUR - unit |
Account Standards | US GAAP | US GAAP | US GAAP | US GAAP | US GAAP |
Shareholder information
Active Capital Investment | |
Free float |
Address
Laboratorio Farmaceutico Erfo S.p.A.
Viale Geki Russo 9
IT-98049 Villafranca Tirrena
Italy
Phone number: +39 090 914 6125
https://www.erfo.it/investor-relations-and-governance/
Contact
Please contact MyQuestion.Italy@euronext.com for Company Profile support.